Three studies presented recently at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain injuries or reduce the risk of stroke altogether. These medications, which lower blood sugar and often cause weight loss, are commonly prescribed for type 2 diabetes and obesity and include drugs like semaglutide (Ozempic).
In the first study, “The Impact of Semaglutide (Ozempic) on Mortality…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply